Acurx Pharmaceuticals Inc

+0.10 (+3.83%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Acurx Pharmaceuticals Inc Stock, NASDAQ:ACXP

259 Liberty Avenue, Staten Island, New York, New York 10305
United States of America
Phone: +1.917.533.1469
Number of Employees: 3


Acurx Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in developing new antibiotics for infections caused by bacteria listed as priority pathogens. Its approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme. Its research and development pipeline includes early-stage antibiotic candidates that target other Gram-positive bacteria, including Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus and Penicillin-Resistant Streptococcus pneumoniae. The company was founded by David P. Luci, Robert G. Shawah and Robert J. DeLuccia in July 2017 and is headquartered in New York, NY.